ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Biofrontera AG

Biofrontera AG (B8F)

0.00
0.00
( 0.00% )
Updated: -
Realtime Data

Biofrontera AG Financial Summary

The current B8F market cap is 0. The company's latest EPS is EUR -0.0058 and P/E is -10408.62.

Year End December 30 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 31.27M30.35M28.79M25.74M32.25M
Operating Income -2.19M-10.03M39.39M-43.05M-2.13M
Net Income -7.36M-13.02M37.75M-44.17M-369k
Year End December 30 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 58.36M56.39M76.13M32.73M30.73M
Total Liabilities 48.41M49.02M18.7M12.39M10.75M
Total Equity 9.96M7.38M57.43M20.34M19.98M

Cash Flow

Year End December 30 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Operating -32.89M-2.85M30.44M-3.9M-1.91M
Investing 21.05M2.87M-42.26M-981k-912k
Financing 3.46M5.95M2.18M4.34M-479k
Market Cap 0
Price to Earnings Ratio -10408.62
Price to Sales Ratio 119.45
Price to Cash Ratio 1.25k
Price to Book Ratio 192.79
Dividend Yield -

Share Statistics

Shares Outstanding 63.81M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change 0.00%
52 Week High 0.398
52 Week Low 0.283
Spread (Intraday) 0 (0%)

Company Info

Company Name Biofrontera AG
Address hemmelrather weg 201
leverkusen 51377
Website https://www.biofrontera.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock